Medication info
Ranitidine Tablets (Ranitidine Hydrochloride)

Ranitidine Tablets (Ranitidine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
Samnam Pharmaceutical Co., Ltd.
Appearance
Round film-coated tablets, beige to yellowish color
Packaging
30 tablets per bottle, 100 tablets per bottle
Approval status
Active

MFDS item code 201607339 · Approved 2016.12.28

Summary

Main use
Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, prevention of Mendelson's syndrome
Who takes it
Adults · Children
Adult dose
Administer orally as ranitidine 150 mg twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer this drug orally at 150 mg twice daily or 300 mg once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same for concomitant therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent the development of gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, or within 8 weeks for conditions caused by nonsteroidal anti-inflammatory drugs, although the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer this drug at 150 mg twice daily for 8 weeks or 300 mg once daily at bedtime. The dose may be increased to 150 mg 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with this drug at an initial dose of 150 mg 3 times daily, and increase the dose as needed. In severe cases, up to 6 g per day may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and administer this drug at 150 mg twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 150 mg of this drug 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the evening before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer this drug at 150 mg once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug; therefore, readjust the dosing schedule immediately after hemodialysis. The dose may be adjusted as appropriate according to age and symptoms.
Child dose
For patients 12 years of age and older, administer this drug orally at 75 mg twice daily (liquid formulation only). For patients 8 〜 18 years of age, up to 150 mg (2 mg per kg of body weight) may be administered twice daily.

Ingredients

Manufacturer
Samnam Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers induced by non-steroidal anti-inflammatory drugs (NSAIDs)
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
  • acute gastritis
View approved original text

This medication is used to treat various gastrointestinal diseases, including gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It also helps prevent Mendelson's syndrome before anesthesia and prevents ulcers after surgery. It is effective in treating gastric and duodenal ulcers induced by non-steroidal anti-inflammatory drugs (NSAIDs). It is also applicable in improving gastric mucosal damage during acute exacerbations of acute and chronic gastritis and upper gastrointestinal bleeding. It can also be used to alleviate symptoms of excess gastric acid, heartburn, and belching. Overall, it helps protect the gastric mucosa and improve symptoms of related diseases.

How to take

Adult dose

Administer orally as ranitidine 150 mg twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer this drug orally at 150 mg twice daily or 300 mg once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same for concomitant therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent the development of gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks, or within 8 weeks for conditions caused by nonsteroidal anti-inflammatory drugs, although the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer this drug at 150 mg twice daily for 8 weeks or 300 mg once daily at bedtime. The dose may be increased to 150 mg 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with this drug at an initial dose of 150 mg 3 times daily, and increase the dose as needed. In severe cases, up to 6 g per day may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and administer this drug at 150 mg twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 150 mg of this drug 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the evening before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer this drug at 150 mg once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the drug; therefore, readjust the dosing schedule immediately after hemodialysis. The dose may be adjusted as appropriate according to age and symptoms.

Child dose

For patients 12 years of age and older, administer this drug orally at 75 mg twice daily (liquid formulation only). For patients 8 〜 18 years of age, up to 150 mg (2 mg per kg of body weight) may be administered twice daily.

Precautions

This medication should not be used in patients who have had an allergic reaction to its ingredients. It should not be administered to patients with a rare condition known as acute porphyria, as it may worsen symptoms. Patients with lactose intolerance or certain genetic metabolic disorders should also avoid this medication. Patients with poor kidney function may require dosage adjustment, as this medication may remain in the body longer, increasing the risk of side effects. Patients with liver dysfunction should also use this medication with caution. Patients with a history of drug allergies and the elderly should be particularly careful when taking this medication. If taking non-steroidal anti-inflammatory drugs concurrently, regular health check-ups are necessary. This medication may mask symptoms of gastric cancer, so patients with gastric ulcers and new indigestion patients over middle age should confirm the malignancy before treatment. If Helicobacter pylori infection is present, eradication therapy should be performed concurrently. During the course of this medication, there may be rare occurrences of severe allergic reactions, blood abnormalities, liver dysfunction, cardiac rhythm disturbances, gastrointestinal issues, and neurological symptoms, so any unusual symptoms should be reported to medical personnel immediately. Dizziness or drowsiness may occur, so it is advised to avoid driving or operating dangerous machinery. This medication can interact with other drugs, affecting their efficacy or side effects, so it is important to inform medical personnel of all medications being taken. Especially when used with anticoagulant medications, blood tests should be performed frequently. Pregnant women or women who may become pregnant and nursing mothers should consider the necessity and risks of using this medication, as its effects on the fetus or infant are not well established. There is a need for caution in using this medication in children, as its safety is not well established. Elderly patients may require careful adjustment of dosage or intervals between doses, as the drug may remain in their bodies for longer due to reduced kidney function. This medication may promote bacterial growth in the stomach by reducing gastric acid secretion, so ophthalmologic examinations may be needed if used long-term. In case of overdose, special toxic symptoms are rare, but suitable treatment such as vomiting or gastric lavage should be administered, and blood dialysis may be performed if necessary.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • elevated serum creatinine levels
Show 56 more
  • leukopenia
  • thrombocytopenia
  • bone marrow suppression
  • aplastic anemia
  • hypoplastic anemia
  • pure red cell aplasia
  • eosinophilia
  • generalized fatigue
  • weakness
  • subcutaneous bleeding
  • mucosal bleeding
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • atrioventricular block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • convulsions
  • headache
  • heaviness
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • altered consciousness
  • hepatic myoclonus
  • gynecomastia
  • hyperprolactinemia
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light; it should be stored in an opaque container. Additionally, it is important to store it at room temperature between 1°C and 30°C to maintain its effectiveness.

Appearance and packaging

Appearance

Round film-coated tablets, beige to yellowish color

Package unit

30 tablets per bottle, 100 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.